All 160 LABU (DIREXION DAILY S&P BIOTECH BULL 3X SHARES DIREXION DAILY S&P BIOTECH BULL 3X SHARES) Holdings
There are 160 LABU holdings. Top 10 companies weight: 101.48%.
Total Market Cap: $1.71T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (160 stocks) | +9.98% | 31.31 | 16.61 | 0.44 | +19.94% | +14.35% | 0.66 | ||||||||||
51 | EXEL | Exelixis Inc | 0.47% | $56.12 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.57 | 0.45 | N/A | N/A | 59 | -9.25% | $51 | +27.07% | 0.52 |
52 | BMRN | Biomarin Pharmaceutical Inc | 0.46% | $59.21 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.56% | $88 | -5.47% | 0.64 |
53 | GILD | Gilead Sciences Inc | 0.46% | $130.28 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +21.51% | $158 | +17.88% | 0.35 |
54 | BIIB | Biogen Inc | 0.45% | $203.16 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +11.39% | $226 | -9.04% | 0.51 |
55 | ALNY | Alnylam Pharmaceuticals Inc | 0.45% | $271.37 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +60.24% | $435 | +8.34% | 0.81 |
56 | ACAD | Acadia Pharmaceuticals Inc | 0.45% | $25.43 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +28.39% | $33 | +2.73% | 0.90 |
57 | IBRX | Immunitybio Inc Ordinary Shares | 0.45% | $8.07 | $8.10B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +61.09% | $13 | -6.28% | 1.57 |
58 | QURE | Uniqure Nv | 0.45% | $40.09 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +61.39% | $65 | +8.64% | 0.99 |
59 | GRAL | Grail Inc | 0.45% | $72.71 | $3.06B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 61 | -3.56% | $70 | 0.00% | 2.23 |
60 | IMVT | Immunovant Inc | 0.45% | $39.53 | $8.13B | Biotechnology | Healthcare | +18.52% | N/A | N/A | N/A | N/A | N/A | 70 | +19.38% | $47 | +31.25% | 1.21 |
61 | BCRX | Biocryst Pharmaceuticals Inc | 0.44% | $9.42 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | N/A | N/A | N/A | -11.11% | N/A |
62 | UTHR | United Therapeutics Corp | 0.44% | $535.83 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.23 | 1.91 | N/A | N/A | 75 | +23.82% | $663 | +23.60% | 0.41 |
63 | NUVL | Nuvalent Inc Class A | 0.44% | $123.96 | $9.75B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 50 | +0.03% | $124 | 0.00% | 0.97 |
64 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.42% | $23.83 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +64.50% | $39 | +4.50% | 1.77 |
65 | CPRX | Catalyst Pharmaceuticals Inc | 0.41% | $31.49 | $3.85B | Biotechnology | Healthcare | +20.98% | 17.44 | 12.95 | 1.73 | N/A | N/A | 54 | +0.57% | $32 | +41.25% | 0.87 |
66 | DNLI | Denali Therapeutics Inc | 0.39% | $23.83 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +43.73% | $34 | -18.07% | 1.46 |
67 | TNGX | Tango Therapeutics Inc | 0.39% | $29.02 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +52.76% | $44 | +21.99% | 1.40 |
68 | VCYT | Veracyte Inc | 0.37% | $59.53 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -5.01% | $57 | +9.24% | 1.36 |
69 | SRPT | Sarepta Therapeutics Inc | 0.37% | $16.21 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.76 | 159.25 | N/A | N/A | 48 | +36.77% | $22 | -25.17% | 1.40 |
70 | IDYA | Ideaya Biosciences Inc | 0.37% | $35.99 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +45.29% | $52 | +10.10% | 1.11 |
71 | NTLA | Intellia Therapeutics Inc | 0.36% | $11.47 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +128.16% | $26 | -40.03% | 1.78 |
72 | AGIO | Agios Pharmaceuticals Inc | 0.36% | $37.36 | $2.37B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +14.08% | $43 | -6.09% | 1.01 |
73 | SNDX | Syndax Pharmaceuticals Inc | 0.36% | $22.64 | $2.08B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +72.26% | $39 | +9.02% | 1.03 |
74 | MLYS | Mineralys Therapeutics Inc | 0.35% | $27.52 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +78.05% | $49 | 0.00% | 0.77 |
75 | ARQT | N/A | 0.35% | $28.26 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | N/A | N/A | N/A | +2.52% | N/A |
76 | CLDX | Celldex Therapeutics Inc | 0.35% | $35.66 | $2.55B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +63.21% | $58 | -4.26% | 1.17 |
77 | VRDN | Viridian Therapeutics Inc | 0.34% | $19.18 | $1.95B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 79 | +88.32% | $36 | +2.18% | 1.09 |
78 | IONS | Ionis Pharmaceuticals Inc | 0.34% | $53.39 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +74.10% | $93 | +7.33% | 0.65 |
79 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.34% | $3.08 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +135.39% | $7.25 | -38.84% | 2.63 |
80 | RCUS | Arcus Biosciences Inc | 0.33% | $29.48 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +21.27% | $36 | -2.24% | 1.50 |
81 | IRON | Disc Medicine Inc Ordinary Shares | 0.32% | $75.58 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +34.36% | $102 | +8.36% | 1.15 |
82 | ADMA | Adma Biologics Inc | 0.31% | $8.59 | $2.02B | Biotechnology | Healthcare | N/A | 12.42 | 10.50 | N/A | N/A | N/A | 75 | +97.90% | $17 | +40.30% | 1.16 |
83 | IMNM | Immunome Inc Ordinary Shares | 0.31% | $22.78 | $2.59B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +57.02% | $36 | +7.24% | 1.64 |
84 | NVAX | Novavax Inc | 0.31% | $8.07 | $1.39B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +74.74% | $14 | -47.88% | 1.45 |
85 | IOVA | Iovance Biotherapeutics Inc | 0.27% | $5.48 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +60.58% | $8.80 | -25.11% | 1.60 |
86 | KOD | Kodiak Sciences Inc | 0.27% | $42.42 | $2.64B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 78 | +47.74% | $63 | -12.93% | 1.69 |
87 | PVLA | Palvella Therapeutics Inc | 0.26% | $143.94 | $2.18B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +59.51% | $230 | 0.00% | 1.03 |
88 | BHVN | Biohaven Ltd | 0.26% | $15.50 | $2.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +46.77% | $23 | 0.00% | 1.46 |
89 | VCEL | Vericel Corp | 0.25% | $46.14 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +23.84% | $57 | -2.68% | 1.13 |
90 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.25% | $23.48 | $2.47B | Biotechnology | Healthcare | +10.31% | N/A | N/A | N/A | N/A | N/A | 81 | +38.42% | $33 | -5.21% | 1.36 |
91 | ABSI | Absci Corp | 0.24% | $8.32 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +65.62% | $14 | -17.36% | 2.33 |
92 | ANAB | Anaptysbio Inc | 0.23% | $53.76 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +62.00% | $87 | +25.59% | 0.81 |
93 | STOK | Stoke Therapeutics Inc | 0.22% | $28.81 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +59.04% | $46 | -1.54% | 1.05 |
94 | VIR | Vir Biotechnology Inc | 0.22% | $9.42 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +128.87% | $22 | -24.08% | 1.52 |
95 | GLUE | Monte Rosa Therapeutics Inc | 0.21% | $23.63 | $1.97B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +40.37% | $33 | +1.29% | 1.31 |
96 | PURR | Hyperliquid Strategies Inc | 0.21% | $7.08 | $1.15B | Capital Markets | Financial Services | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +84.32% | $13 | 0.00% | 3.35 |
97 | CAPR | Capricor Therapeutics Inc | 0.20% | $19.79 | $1.17B | Biotechnology | Healthcare | +22.65% | N/A | 78.74 | N/A | N/A | N/A | 80 | +170.84% | $54 | +32.81% | 1.45 |
98 | TYRA | Tyra Biosciences Inc | 0.20% | $31.85 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +63.17% | $52 | 0.00% | 1.02 |
99 | CRVS | Corvus Pharmaceuticals Inc | 0.20% | $14.47 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +130.34% | $33 | +43.84% | 0.76 |
100 | CGEM | Cullinan Therapeutics Inc | 0.19% | $18.06 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +74.70% | $32 | -7.12% | 1.06 |
LABU (DIREXION DAILY S&P BIOTECH BULL 3X SHARES DIREXION DAILY S&P BIOTECH BULL 3X SHARES) Sector Allocation
HEALTHCARE
44.70%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%